348 related articles for article (PubMed ID: 34234365)
21. Efficacy and safety of combination therapy with sodium-glucose cotransporter 2 inhibitors and renin-angiotensin system blockers in patients with type 2 diabetes: a systematic review and meta-analysis.
Tian B; Deng Y; Cai Y; Han M; Xu G
Nephrol Dial Transplant; 2022 Mar; 37(4):720-729. PubMed ID: 33605424
[TBL] [Abstract][Full Text] [Related]
22. Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension.
Matchar DB; McCrory DC; Orlando LA; Patel MR; Patel UD; Patwardhan MB; Powers B; Samsa GP; Gray RN
Ann Intern Med; 2008 Jan; 148(1):16-29. PubMed ID: 17984484
[TBL] [Abstract][Full Text] [Related]
23. Amlodipine and angiotensin-converting enzyme inhibitor combination versus amlodipine monotherapy in hypertension: a meta-analysis of randomized controlled trials.
Lv Y; Zou Z; Chen GM; Jia HX; Zhong J; Fang WW
Blood Press Monit; 2010 Aug; 15(4):195-204. PubMed ID: 20512032
[TBL] [Abstract][Full Text] [Related]
24. Effect of the Renin-Angiotensin System Inhibitors on Inflammatory Markers: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Awad K; Zaki MM; Mohammed M; Lewek J; Lavie CJ; Banach M;
Mayo Clin Proc; 2022 Oct; 97(10):1808-1823. PubMed ID: 36202494
[TBL] [Abstract][Full Text] [Related]
25. Short- and long-term outcomes with renin-angiotensin-aldosterone inhibitors in renal transplant recipients: A meta-analysis of randomized controlled trials.
Liao RX; Lyu XF; Tang WJ; Gao K
Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28186357
[TBL] [Abstract][Full Text] [Related]
26. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
27. Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis.
Caldeira D; Alarcão J; Vaz-Carneiro A; Costa J
BMJ; 2012 Jul; 345():e4260. PubMed ID: 22786934
[TBL] [Abstract][Full Text] [Related]
28. A systematic review and network meta-analysis of the comparative efficacy of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension.
Dimou C; Antza C; Akrivos E; Doundoulakis I; Stabouli S; Haidich AB; Kotsis V
J Hum Hypertens; 2019 Mar; 33(3):188-201. PubMed ID: 30518809
[TBL] [Abstract][Full Text] [Related]
29. Impact of renin-angiotensin system inhibitors on mortality and major cardiovascular endpoints in hypertension: A number-needed-to-treat analysis.
Brugts JJ; van Vark L; Akkerhuis M; Bertrand M; Fox K; Mourad JJ; Boersma E
Int J Cardiol; 2015 Feb; 181():425-9. PubMed ID: 25569271
[TBL] [Abstract][Full Text] [Related]
30. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis.
Cheng J; Zhang W; Zhang X; Han F; Li X; He X; Li Q; Chen J
JAMA Intern Med; 2014 May; 174(5):773-85. PubMed ID: 24687000
[TBL] [Abstract][Full Text] [Related]
31. Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease.
Kunz R; Friedrich C; Wolbers M; Mann JF
Ann Intern Med; 2008 Jan; 148(1):30-48. PubMed ID: 17984482
[TBL] [Abstract][Full Text] [Related]
32. Effect on the atherogenic marker plasminogen activator inhibitor type-1 of addition of the ACE inhibitor imidapril to angiotensin II type 1 receptor antagonist therapy in hypertensive patients with abnormal glucose metabolism: a prospective cohort study in primary care.
Yajima K; Shimada A; Hirose H; Oikawa Y; Yamada S; Meguro S; Irie J; Irie S
Clin Drug Investig; 2009; 29(12):811-9. PubMed ID: 19888787
[TBL] [Abstract][Full Text] [Related]
33. Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis.
Wang B; Wang F; Zhang Y; Zhao SH; Zhao WJ; Yan SL; Wang YG
Lancet Diabetes Endocrinol; 2015 Apr; 3(4):263-74. PubMed ID: 25660574
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitors in Combination with Angiotensin-Receptor Blockers in Nondiabetic Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
Zhao M; Ma S; Yu Y; Wang R; Chang M; Zhang H; Qu H; Zhang Y
Curr Med Chem; 2021; 28(38):7961-7973. PubMed ID: 34126881
[TBL] [Abstract][Full Text] [Related]
35. Updated report on comparative effectiveness of ACE inhibitors, ARBs, and direct renin inhibitors for patients with essential hypertension: much more data, little new information.
Powers BJ; Coeytaux RR; Dolor RJ; Hasselblad V; Patel UD; Yancy WS; Gray RN; Irvine RJ; Kendrick AS; Sanders GD
J Gen Intern Med; 2012 Jun; 27(6):716-29. PubMed ID: 22147122
[TBL] [Abstract][Full Text] [Related]
36. The effects of incretin-based therapies on β-cell function and insulin resistance in type 2 diabetes: A systematic review and network meta-analysis combining 360 trials.
Wu S; Gao L; Cipriani A; Huang Y; Yang Z; Yang J; Yu S; Zhang Y; Chai S; Zhang Z; Sun F; Zhan S
Diabetes Obes Metab; 2019 Apr; 21(4):975-983. PubMed ID: 30536884
[TBL] [Abstract][Full Text] [Related]
37. Telmisartan Improves Insulin Resistance: A Meta-Analysis.
Wang Y; Qiao S; Han DW; Rong XR; Wang YX; Xue JJ; Yang J
Am J Ther; 2018; 25(6):e642-e651. PubMed ID: 29557807
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin II receptor blockers for the treatment of portal hypertension in patients with liver cirrhosis: a systematic review and meta-analysis of randomized controlled trials.
Yao H; Zhang C
Ir J Med Sci; 2018 Nov; 187(4):925-934. PubMed ID: 29470765
[TBL] [Abstract][Full Text] [Related]
39. Effects of ACEIs Versus ARBs on Proteinuria or Albuminuria in Primary Hypertension: A Meta-Analysis of Randomized Trials.
Xu R; Sun S; Huo Y; Yun L; Huang S; Li G; Yan S
Medicine (Baltimore); 2015 Sep; 94(39):e1560. PubMed ID: 26426627
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
